Columbia Wanger Asset Management’s Idexx Laboratories IDXX Stock Holding History

Columbia Wanger Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$18.8M	Hold	120,199	–	–	0.28%	145
2017 Q3	$18.7M	Buy	120,199 +4,116	+4%	+$651K	0.28%	140
2017 Q2	$18.7M	Sell	116,083 -48,178	-29%	-$7.82M	0.27%	151
2017 Q1	$25.4M	Sell	164,261 -18,971	-10%	-$2.62M	0.36%	123
2016 Q4	$21.5M	Sell	183,232 -41,380	-18%	-$4.72M	0.3%	143
2016 Q3	$25.3M	Sell	224,612 -145,827	-39%	-$15.4M	0.33%	129
2016 Q2	$34.4M	Sell	370,439 -678,561	-65%	-$58.3M	0.4%	117
2016 Q1	$82.2M	Buy	+1,049,000	New	+$75.5M	0.88%	28

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Columbia Wanger Asset Management's IDXX Position: Q4 2017 in Review

Columbia Wanger Asset Management held its Idexx Laboratories (IDXX) position steady in Q4 2017 at 120,199 shares worth $18.8M. The position accounts for 0.28% of the portfolio, ranked #145.

Columbia Wanger Asset Management first reported a position in IDXX in Q1 2016 and has held it in 8 quarters since. The position peaked at $82.2M in Q1 2016. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

Columbia Wanger Asset Management held 120,199 shares of Idexx Laboratories worth $18.8M as of Q4 2017.
Columbia Wanger Asset Management left its Idexx Laboratories share count unchanged in Q4 2017.
Idexx Laboratories made up 0.28% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #145 holding.
Columbia Wanger Asset Management first reported a position in Idexx Laboratories in Q1 2016 and has held it in 8 quarters since.
Columbia Wanger Asset Management's Idexx Laboratories position peaked at $82.2M in Q1 2016.
613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.